Blog
Understanding Onyda XR: A New Option for ADHD and Beyond
One of the medications our medication management team utilizes for patients with ADHD is Onyda X — a once-daily, non-stimulant liquid formulation approved for ADHD treatment in children aged six and older.
Differentiating ADHD from Bipolar Disorder
Differentiating between ADHD and bipolar disorder, particularly Bipolar II, is vital for accurate diagnosis and effective treatment. This blog explores the key differences between these conditions to help patients better understand their experiences and seek appropriate care.
The Cognitive Benefits of L-Theanine and Caffeine: Insights from Recent Research
Discover how the combination of L-theanine and caffeine enhances cognition, focus, and stress management based on recent research insights. Learn how Philadelphia Integrative Psychiatry integrates these findings into personalized care plans.
The Transformative Power of Executive Function Coaching for ADHD
Discover how Executive Function Coaching at Philadelphia Integrative Psychiatry transforms lives by improving behaviors, resilience, and goal attainment for ADHD patients.